Biohaven Pharma (BHVN) Misses Q4 EPS by 22c, Revenue Beats

Go back to Biohaven Pharma (BHVN) Misses Q4 EPS by 22c, Revenue Beats
(NYSE: BHVN) Delayed: 14.64 -0.21 (1.41%)
Previous Close $14.85    52 Week High
Open $14.79    52 Week Low
Day High $14.96    P/E N/A 
Day Low $14.31    EPS
Volume 1,244,136